Riva, P <br/><br/>
Treatment of intracranial human glioblastoma by direct intratumoral administration of 131I-labelled anti-tenascin monoclonal antibody BC-2.  [electronic resource] 

 -  International journal of cancer  Apr 1992 
 - 7-13 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0020-7136 
<br/><br/><label>Standard No.: </label>10.1002/ijc.2910510103  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibody Specificity<br/>Brain Neoplasms--radiotherapy<br/>Cell Adhesion Molecules, Neuronal--immunology<br/>Extracellular Matrix Proteins--immunology<br/>Female<br/>Glioma--radiotherapy<br/>Humans<br/>Injections, Intralesional<br/>Iodine Radioisotopes--therapeutic use<br/>Male<br/>Middle Aged<br/>Neoplasm Proteins--immunology<br/>Neoplasm Recurrence, Local--radiotherapy<br/>Radioimmunotherapy<br/>Radiotherapy Dosage<br/>Tenascin